Fundraising Fox

Sensorium Therapeutics

3 known investors

sensorium.bio ↗

Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.

AI & Machine LearningBiotechDigital Health

Investors · 3

Mission BiocapitalSan Francisco · $500K – $500K
Service Provider CapitalVail
Route 66 Venturesreported$500K – $4M

In the news